University of Maryland - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
42
About the Report
About the Report
Summary
University of Maryland (UMD) is a research university that operates colleges and schools. The university offers academic departments and programs including agricultural and resource economics, American studies, animal and avian sciences, anthropology, applied mathematics and scientific computation program, Arabic studies, behavioral and community health, biochemistry, bioengineering, and chemical physics program, among others. It provides services to college of agriculture and natural resources, school of architecture, planning, and preservation, college of arts and humanities, college of behavioral and social sciences, robert h. smith school of business, college of computer, and college of education, among others. The university also offers graduation, post graduation, and phd courses. UMD is headquartered in College Park, Maryland, the US.
University of Maryland-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
University of Maryland, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Maryland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Maryland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Maryland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Maryland, Medical Devices Deals, 2012 to YTD 2018 9
University of Maryland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University of Maryland, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
University of Maryland Enters Into Licensing Agreement With Harpoon Medical 12
Innovate Biopharma Enters into R&D Agreement with University of Maryland School of Medicine 13
Institute for Bioscience and Biotechnology Research Enters into Partnership with Frederick National Lab 14
GeoVax Labs Enters into Agreement with Scripps Research Institute and Institute of Human Virology 15
Genisphere Enters into Research Agreement with University of Maryland 16
ConverGene Enters into Research Agreement with University of Maryland School of Medicine 17
ImmunoCellular Therapeutics Enters into Research Agreement with University of Maryland, Baltimore 18
Nosocomial Vaccine Enters into Agreement with Affinivax and University of Maryland 19
University Of Maryland School Of Medicine Enters Into Co-Development Agreement With MRIGlobal Dx 20
Licensing Agreements 21
Cellth Systems Enters into Licensing Agreement with University of Maryland 21
Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 22
Rexahn Pharma Enters Into Licensing Agreement With University of Maryland For Nano-Polymer-Drug Conjugate Systems 23
Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 24
Educational and Scientific Enters into Licensing Agreement with University of Maryland 25
SilcsBio Enters Into Licensing Agreement With UM Ventures 26
University of Maryland-Key Competitors 27
University of Maryland-Key Employees 28
University of Maryland-Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 31
Government and Public Interest 31
Sep 04, 2018: UIC to lead study of negative pressure wound therapy in obese and diabetic patients 31
Aug 30, 2018: Avera Research receives USD 17.1 million National Institutes of Health grant 32
Aug 21, 2018: Mason researcher part of team awarded USD 2.5 million grant for investigating remedies to deadly virus 33
Feb 08, 2018: UMD Researchers Develop Breakthrough Technique to Combat Cancer Drug Resistance 34
Oct 27, 2017: New molecule shows promise in HIV vaccine design 35
Mar 29, 2017: NIH R01 Award to Develop Next Generation Non-nucleoside RT HIV Inhibitors 36
Product News 37
Dec 06, 2017: The Leukemia & Lymphoma Society Achieves New Milestones in Offensive Against Acute Myeloid Leukemia, Deadly Blood Cancer 37
08/03/2017: UM SOM Received USD 2.47 Million Grant To Develop Traveler's Diarrhea Vaccine 39
Jun 13, 2017: UMD bioengineers develop new technologies to drive next-generation therapies for MS 40
Other Significant Developments 41
Jul 31, 2018: New cell lines produce nist monoclonal antibody for improved manufacturing of biologic drugs 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Figure
List of Figures
University of Maryland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Maryland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Maryland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Maryland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Maryland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Maryland, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
University of Maryland, Pharmaceuticals & Healthcare, Key Facts 2
University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Maryland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Maryland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Maryland, Deals By Therapy Area, 2012 to YTD 2018 8
University of Maryland, Medical Devices Deals, 2012 to YTD 2018 9
University of Maryland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University of Maryland Enters Into Licensing Agreement With Harpoon Medical 12
Innovate Biopharma Enters into R&D Agreement with University of Maryland School of Medicine 13
Institute for Bioscience and Biotechnology Research Enters into Partnership with Frederick National Lab 14
GeoVax Labs Enters into Agreement with Scripps Research Institute and Institute of Human Virology 15
Genisphere Enters into Research Agreement with University of Maryland 16
ConverGene Enters into Research Agreement with University of Maryland School of Medicine 17
ImmunoCellular Therapeutics Enters into Research Agreement with University of Maryland, Baltimore 18
Nosocomial Vaccine Enters into Agreement with Affinivax and University of Maryland 19
University Of Maryland School Of Medicine Enters Into Co-Development Agreement With MRIGlobal Dx 20
Cellth Systems Enters into Licensing Agreement with University of Maryland 21
Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 22
Rexahn Pharma Enters Into Licensing Agreement With University of Maryland For Nano-Polymer-Drug Conjugate Systems 23
Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 24
Educational and Scientific Enters into Licensing Agreement with University of Maryland 25
SilcsBio Enters Into Licensing Agreement With UM Ventures 26
University of Maryland, Key Competitors 27
University of Maryland, Key Employees 28
University of Maryland, Subsidiaries 29
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.